Substrate ARC: Autonomous Revenue Cycle ads, reviews and marketing in August 2026
They position Substrate as an autonomous healthcare revenue-cycle system that recovers denied revenue and improves practice economics. Their ads rely on repeated proof points around denial leakage, fast deployment, hands-free work, and EBITDA impact. You can compete by making your mechanism, measurement rules, implementation effort, and human controls more explicit.
- Researched
- 29 August 2026
- Site
- substrate.cc
- Ads read in
- US
- Sources
- 1 of 9 answered
- 23
- ads found
- 0
- reviews found
- 1
- sources read
- Not rated
- review rating
Best opening
Positioning
10 of their 23 ads focus on denial recovery, so define your advantage around a narrower mechanism or a clearer recovery boundary.
Moves worth carrying forward
Creative
7 of their 23 ads use numeric proof, so make each number auditable with its population, baseline, and measurement period.
Guardrail
6 of their 23 ads promise hands-free or rapid operation, so state where human review remains necessary and what happens when automation cannot decide.
What Substrate ARC: Autonomous Revenue Cycle is running
Substrate ads, read · 23 of 23 read one by one · 2026-08-29T14:37:38.856Z
They run a tightly repeated healthcare revenue-cycle message: denials and payer delays create lost revenue, while ARC recovers it hands-free. Their strongest proof is numeric, with repeated claims around 48-hour results, denial recovery, EBITDA, and lower collection cost. You can attack the repetition by showing your mechanism, evidence boundaries, and workflow coverage before making a broad recovery claim.
- 23
- active ads
- 4%
- video
- 0
- median days running
- 0
- longest run, days
- 23
- creative variants
- not read
- EU reachno detail pass yet
Format
Running for
23 of 23 ads · fetched 2026-08-29 · first run, nothing to compare against
Payers deny, delay, and wait for you to give up. Most of what you write off was winnable. Most denial tools just flag wh… Get paid what payers owe you.
US
Your company has a lot of cash sitting in unpaid claims. That's your money, and you can't use it until payers actually p… Your cash is stuck in payer queues. V7 — AR Universa
US
Up to 60% fewer eligibility-driven denials. 24 hours from contract to first live results. Zero EMR integration required.… Substrate Eligibility. Live in days. No integration. V6 Eligibility Proof — Jun 2026
US
Providers lost $38.6 billion to denials and uncollected claims in 2024, up 25% the next year (Kodiak). Denials get aband… Recover the denials you write off today
US
Most denial tools just predict which claims to chase or draft a letter. Substrate ARC works the whole denial: it reads t… Denials Resolution, handsfree
US
No team can clear their AR backlog to zero by hand and keep it there. Substrate ARC works every denial in the pile, smal… Backlog Zero. Finally possible.
US
Research receiptSources, retention and creditsHide details
What this run read
12 credits spent
Ad copy and review text are quoted from the linked public pages.
This is a public page on kamplyapp.com. It stays up until its owner takes it down.
